轴突初始段可塑性的改变与阿尔茨海默氏病的早期病原发生有关
Yu Li1, Han Wang1, Yiming Wang1
1State Key Laboratory of Membrane Biology School of Life Sciences Peking University Beijing China.
MedComm
|October 17, 2024
概括
阿尔茨海默病涉及轴突初始段 (AIS) 的早期变化,这是一个关键的神经元结构. 在AIS中恢复特定的ankyrin G异型可以改善神经元功能,为阿尔茨海默病提供潜在的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 神经退行性疾病 神经退行性疾病
- 细胞生物学 细胞生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种流行的神经退行性疾病,由粉样β和病理学标志着.
- 早期发现神经病理变化对于及时干预阿尔茨海默病至关重要.
- 轴突初始段 (AIS) 对于神经元结构和动作潜力的启动至关重要.
研究的目的:
- 为了研究在AD发病的早期阶段AIS的变化.
- 探索安基林G (AnkG) 在与AD相关的AIS功能障碍中的作用.
- 评估在AD模型中针对AIS完整性的治疗潜力.
主要方法:
- 使用了具有家族AD突变的APP/PS1小鼠模型.
- 通过免疫染色和补丁来评估AIS长度和电生理学特性.
- 通过西方抹黑和救援实验评估了ankyrin G (AnkG) 表达和功能.
主要成果:
- 在APP/PS1小鼠中观察到显著的AIS缩短,与行动潜力的传播受损相关.
- 在受影响的神经元中发现了480 kDa的AnkG异型的减少.
- 恢复480kDa的AnkG异形使AIS可塑性正常化,并增强了长期的潜能.
结论:
- AIS可塑性改变和AnkG失调被认为是阿尔茨海默病的早期事件.
- 480kDa的AnkG异型在维护AIS完整性方面发挥着至关重要的作用.
- 通过480kDa的AnkG异型恢复AIS完整性,为AD提供了一个潜在的治疗策略.
更多相关视频
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
23.2K
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
94.0K
相关概念视频
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Alzheimer's Disease: Treatment
166
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
166
Neuroplasticity
303
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
303
